Search results
Results From The WOW.Com Content Network
This is the list of Schedule III controlled substances in the United States as defined by the Controlled Substances Act at 21 U.S.C. ยง 812 (c) and 21 CFR 1308.13. The following findings are required for substances to be placed in this schedule: [ 1]
[66] [4] In addition, research shows certain substances on Schedule I, for drugs which have no accepted medical uses and high potential for abuse, actually have accepted medical uses, have low potential for abuse, or both. [67] [68] [69] One of those substances is cannabis, which is either decriminalized or legalized in 33 states of the United ...
Schedule 3 Recordable (S3R), or "recordable potent substances", refers to Pharmacist Only Medicines where supply is recorded as for Schedule 4 drugs. S3R drugs are those that may have an increased risk of illegal diversion or abuse. These are specified in Clause 23 of the Poisons and Therapeutic Goods Regulation 2002 (NSW). As of January 2006 ...
Schedule 3 drugs, while still OTC, can only be dispensed after consultation with a pharmacist. It is a Schedule 4 (prescription only) drug when compounded with one or more other therapeutically active substances and not exceeding 100 mg dihydrocodeine per dose. [ 27 ]
Midazolam is a Schedule IV drug under the Convention on Psychotropic Substances. [80] In the United Kingdom, midazolam is a Schedule 3/Class C controlled drug. [ 81 ] In the United States, midazolam (DEA number 2884) is on the Schedule IV list of the Controlled Substances Act as a non-narcotic agent with low potential for abuse.
The Schedule 3 list is one of three lists. Chemicals which can be used as weapons, or used in their manufacture, but which have no, or almost no, legitimate applications as well are listed in Schedule 1, whilst Schedule 2 is used for chemicals which have legitimate small-scale applications. The use of Schedule 1, 2, or 3 chemicals as weapons is ...
This is the list of Schedule IV controlled substances in the United States as defined by the Controlled Substances Act. [1] The following findings are required for substances to be placed in this schedule: [2] The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule III.
Codeine is marketed as both a single-ingredient drug and in combination preparations with paracetamol (as co-codamol: e.g., brands Paracod, Panadeine, and the Tylenol-with-codeine series, including Tylenol 3 and 1, 2, and 4); with aspirin (as co-codaprin ); or with ibuprofen (as Nurofen Plus ). These combinations provide greater pain relief ...